Companies /Healthcare

Enveric Biosciences Inc

NASDAQ: ENVB Biotechnology
$1.37
â–² $0.00 (+0.00%) today
Markets closed · 4:59am ET
Today · % change

Fundamentals

Market Cap
$6.1M
Revenue (TTM)
$35.4M
EPS (TTM)
$-11.43
52-Week Range
$1 – $15
Street Target
$10.00

About Enveric Biosciences

Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.

ENVB Coverage